{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:15:41Z","timestamp":1781500541741,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jpba.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T18:51:47Z","timestamp":1368903107000},"page":"279-285","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Biorelevant solubility of poorly soluble drugs: Rivaroxaban, furosemide, papaverine and niflumic acid"],"prefix":"10.1016","volume":"83","author":[{"given":"Krisztina","family":"Tak\u00e1cs-Nov\u00e1k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Sz\u0151ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"V\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ambrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piroska","family":"Szab\u00f3-R\u00e9v\u00e9sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.05.011_bib0005","series-title":"Absorption and Drug Development: Solubility, Permeability and Charge State","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.jpba.2013.05.011_bib0010","series-title":"Physico-Chemical Methods in Drug Discovery and Development","first-page":"1","article-title":"Physicochemical profiling in drug research and development","author":"Tak\u00e1cs-Nov\u00e1k","year":"2012"},{"key":"10.1016\/j.jpba.2013.05.011_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ddtec.2004.08.011","article-title":"Physicochemical profiling: overview of the screens","volume":"1","author":"Kerns","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jpba.2013.05.011_bib0020","series-title":"Drug-like Properties: Concepts, Structure design and Methods: From ADME to Toxicity Optimization","author":"Kerns","year":"2008"},{"key":"10.1016\/j.jpba.2013.05.011_bib0025","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2174\/138161209788682479","article-title":"Drug-like property concepts in pharmaceutical design","volume":"15","author":"Di","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2013.05.011_bib0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.addr.2007.05.007","article-title":"High throughput solubility measurement in drug discovery and development","volume":"59","author":"Alsenz","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2013.05.011_bib0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical bases for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.05.011_bib0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.05.011_bib0045","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media stimulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.05.011_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissol. Technol."},{"key":"10.1016\/j.jpba.2013.05.011_bib0060","first-page":"147","article-title":"Micellar solubilization of drugs","volume":"8","author":"Rangel-Yagui","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2013.05.011_bib0065","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/mp100049m","article-title":"Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media","volume":"7","author":"Fagerberg","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejps.2010.07.012","article-title":"What is modulating solubility in simulated intestinal fluids?","volume":"41","author":"Ottaviani","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2013.05.011_bib0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejps.2011.04.016","article-title":"Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids","volume":"43","author":"Clarysse","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2013.05.011_bib0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measured by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.05.011_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0003-2670(01)00810-8","article-title":"Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study","volume":"434","author":"Tam","year":"2001","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.05.011_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-5173(92)90099-N","article-title":"Lipophilicity of antibacterial fluoroquinolones","volume":"79","author":"Tak\u00e1cs-Nov\u00e1k","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-5173(94)00176-6","article-title":"Lipophilicity of amphoteric molecules expressed by the true partition coefficient","volume":"113","author":"Tak\u00e1cs-Nov\u00e1k","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.aca.2010.05.022","article-title":"Study of pH-dependent solubility of organic bases. Revisit of Henderson\u2013Hasselbalch relationship","volume":"673","author":"V\u00f6lgyi","year":"2010","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.05.011_bib0105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0731-7085(94)00090-5","article-title":"Determination of protonation macro- and microconstants and octanol\/water partition coefficient of antiinflammatory drug niflumic acid","volume":"12","author":"Tak\u00e1cs-Nov\u00e1k","year":"1994","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1016\/j.jpba.2013.05.011_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(97)04907-7","article-title":"Potentiometric pKa determination of water-insoluble compounds: validation study in methanol\/water mixtures","volume":"151","author":"Tak\u00e1cs-Nov\u00e1k","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpba.2011.05.007","article-title":"Biorelevant pKa (37\u00b0C) predicted from the 2D structure of the molecule and its pKa at 25\u00b0C","volume":"56","author":"Sun","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.05.011_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2003.10.016","article-title":"Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs","volume":"270","author":"Yu","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2013.05.011_bib0125","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s11095-008-9679-z","article-title":"Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional Wood's apparatus","volume":"25","author":"Avdeef","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.05.011_bib0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejps.2011.06.009","article-title":"Lipophilicity of zwitterions and related species: a new insight","volume":"44","author":"Maz\u00e1k","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2013.05.011_bib0135","first-page":"331","article-title":"Importance de la dissociation ionique des medicaments en pharmacocin\u00e9tique. M\u00e9thodes de d\u00e9termination de leur pKa","volume":"36","author":"Bres","year":"1976","journal-title":"Trav. Soc. Pharm. Montp."},{"key":"10.1016\/j.jpba.2013.05.011_bib0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpba.2007.01.039","article-title":"Thermodynamic properties of flufenamic and niflumic acids \u2013 specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution","volume":"45","author":"Perlovich","year":"2007","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T19:22:18Z","timestamp":1539631338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":28,"alternative-id":["S0731708513002124"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.05.011","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}